NLRP3 and polycystic ovary syndrome: In addition, future research could also explore the possible effect of weight loss intervention on emerging inflammatory pathways including the NLRP3 inflammasome and its related components (such as Casp-1, ASC, and IL-1β) in PCOS patients.